MAP1LC3B and colorectal carcinoma: As shown in Fig. S5D, KS-20073 and KS-20226 remarkably increased LC3B expression, suggesting that IRP2 inhibition leads to CRC cell death relying on activation of the AMPK-ULK1-Beclin1 pathway.